ELEDON PHARMACEUTICALS, INC.
Profile
Company Names
ELEDON PHARMACEUTICALS, INC.
NOVUS THERAPEUTICS, INC.
TOKAI PHARMACEUTICALS INC
Addresses
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA 92612
19900 MACARTHUR BLVD., SUITE 550, IRVINE, CA 92612
19900 MACARTHUR BLVD., SUITE 550, IRVINE, CA 92612
19900 MACARTHUR BOULEVARD, SUITE 550, IRVINE, CA 92612
1 BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
Phone Numbers
949-238-8090
(949) 238-8090
617-225-4305
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DE
Total Amount Raised:
$226,760,504.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-05-09
$49,999,010.00
INDEFINITE
INDEFINITE
Equity
7
2023-05-05
$35,000,000.00
INDEFINITE
INDEFINITE
Equity
6
2020-09-15
$108,144,151.00
$108,144,151.00
$0.00
Equity
5
2020-01-14
$862,278.00
$5,828,999.00
$4,966,721.00
4
2019-05-02
$862,278.00
$28,455,174.00
$27,592,896.00
3
2013-05-13
$19,999,993.00
$35,499,985.00
$15,499,992.00
Equity
2
2011-09-09
$1,892,794.00
$22,999,986.00
$21,107,192.00
Equity
1
2009-05-06
$10,000,000.00
$22,000,000.00
$12,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
REINHARD
J.
AMBROS
DIRECTOR
TIMOTHY
BARBERICH
DIRECTOR
TIMOTHY
J.
BARBERICH
DIRECTOR
EREZ
CHIMOVITS
DIRECTOR
DAVID-ALEXANDRE
GROS
EXECUTIVE OFFICER, DIRECTOR
SETH
L.
HARRISON
EXECUTIVE OFFICER, DIRECTOR
KEITH
A.
KATKIN
DIRECTOR
DAVID
KESSLER
DIRECTOR
PAUL
LITTLE
EXECUTIVE OFFICER
GARY
LYONS
DIRECTOR
JOHN
MCBRIDE
DIRECTOR
CAMPBELL
MURRAY
DIRECTOR
ALIOS BIOPHARMA INC
| TOKAI PHARMACEUTICALS INC
| AILERON THERAPEUTICS INC
| BIORELIX INC
| EUTHYMICS BIOSCIENCE INC
| AKEBIA THERAPEUTICS, INC.
| AERPIO THERAPEUTICS, INC.
| NEUROVANCE, INC.
| EBI LIFE SCIENCES, INC.
| IMAGINAB, INC.
| GALERA THERAPEUTICS, INC.
| BIONANO GENOMICS, INC
| EUTHYMICS BIOSCIENCE, INC.
| ICEBREAKER HEALTH, INC.
| ANNEXON, INC.
| TSCAN THERAPEUTICS, INC.
| RENOVACOR, INC.
| LIGHTHOUSE PHARMACEUTICALS, INC.
WALTER
OGIER
DIRECTOR
STEVEN
PERRIN
EXECUTIVE OFFICER, DIRECTOR
JAMES
ROBINSON
DIRECTOR
BRYAN
SMITH
EXECUTIVE OFFICER
HOMEFRONT LEARNING CENTER INC
| CROWLEY HOLDINGS PREFERRED, LLC
| CROWLEY HOLDINGS, INC.
| HOPEBRIDGE, LLC
| RISKLENS, INC.
| CARLYLE PROPERTY INVESTORS (MASTER REIT), L.L.C.
| CRP VII SEATTLE SENIOR LIVING COINVESTMENT, L.P.
| CRP VII LEXINGTON LIFE SCIENCE COINVESTMENT, L.P.
| LSC LITHIUM CORP
| CARLYLE REALTY PARTNERS VIII REIT, L.L.C.
| BROOKFIELD SENIOR MEZZANINE REAL ESTATE FINANCE FUND L.P.
| TAMUS ARS FUND LP
| WILLIAM FUND, LLC
| BROOKFIELD PREMIER REAL ESTATE PARTNERS L.P.
| BROOKFIELD PREMIER REAL ESTATE PARTNERS BPY LLC
| BROOKFIELD PREMIER REAL ESTATE PARTNERS (NUS) L.P.
| NSSA EDC REIT LLC
| BSREP III PISCES REIT LLC
| BSREP III NORMA REIT LLC
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS IV-A L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS IV-B L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS IV-C L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS IV-C (ER) SCSP
| BROOKFIELD REAL ESTATE SECONDARIES A L.P.
| BROOKFIELD REAL ESTATE SECONDARIES B L.P.
| BROOKFIELD REAL ESTATE SECONDARIES C L.P.
| DREAMSCAPE ENTERTAINMENT PROPERTIES, INC.
| ELEDON PHARMACEUTICALS, INC.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-A L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-B L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-C L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-C (ER) SCSP
| BROOKFIELD PREMIER REAL ESTATE PARTNERS (NUS TE) L.P.
| BROOKFIELD SINGLE FAMILY RENTAL II L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-C (U) L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-A (U) L.P.
| BROOKFIELD STRATEGIC REAL ESTATE PARTNERS V-B (U) L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-15
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
